Brennan John Owen's Form 4 filing
ImmunityBio, Inc. (IBRX) · filed Jun 5, 2023
- Accession no.
- 0001326110-23-000071
- Filed
- Jun 5, 2023
- Trade date
- Jun 2, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $70.7K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brennan John OwenCIK 0001849620 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2023 | Common Stock | PPurchaseAcquired | +5,000 | $2.74 | +$13,700 | 5,000 | Direct | |
| Jun 2, 2023 | Common Stock | PPurchaseAcquired | +10,000 | $2.80 | +$28,000 | 15,000 | Direct | |
| Jun 2, 2023 | Common Stock | PPurchaseAcquired | +10,000 | $2.90 | +$29,000 | 25,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.